| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.6 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |